The role of E-cadherin in low-grade ductal breast tumourigenesis

Journal of Pathology

Volumn 200, Issue 1, 2003, Pages 53-58

  Roylance, Rebecca ^a   Droufakou, Stavroula ^b   Gorman, Patricia ^a   Gillett, Cheryl ^c   Hart, Ian R ^b   Hanby, Andrew ^d   Tomlinson, Ian ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Allele imbalance; E cadherin; Grade I ductal breast cancer; Immunohistochemistry

Indexed keywords

UVOMORULIN;

ALLELIC IMBALANCE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ALLELES; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NEOPLASM INVASIVENESS;

EID: 0038663231     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1326     Document Type: Article

References (26)

1. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107-6115.
2. Droufakou S, Deshmane V, Roylance R, et al. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 2001; 92: 404-408.
3. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
4. Berx G, Becker K-F, Hotler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Murat 1998; 12: 226-237.
5. Berx G, Cleton-Jansen AM, Strumane K, et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996; 13: 1919-1925.
6. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142: 987-993.
7. Berx G, Nollet F, Van Roy F. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun 1998; 6: 171-184.
8. Gillett CE, Miles DW, Ryder K, et al. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. J Pathol 2001; 193: 433-441.
9. Tan DS, Potts HW, Leong AC, et al. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast. J Pathol 1999; 189: 20-27.
10. Dorion-Bonnet F, Mautalen S, Hostein I, et al. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer 1995; 14: 171-181.
11. Skirnisdottir S, Eiriksdottir G, Baldursson T, et al. High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S phase. Int J Cancer 1995; 64: 112-116.
12. Kashiwaba M, Tamura G, Suzuki Y, et al. Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Jpn J Cancer Res 1995; 86: 1054-1059.
13. Roylance R, Gorman P, Harris W, et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 1999; 59: 1433-1436.
14. Nishizaki T, Chew K, Chu L, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997; 74: 513-517.
15. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
16. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976; 3: 2303-2308.
17. Roylance R, Gorman P, Hanby A, et al. Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol 2002; 196: 32-36.
18. Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci U S A 1993; 90: 10 325-10 329.
19. Moll R, Mitze M, Frixen UH, et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143: 1731-1742.
20. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biol 2000; 2: 84-89.
21. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial - mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biol 2000; 2: 76-83.
22. Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267-1278.
23. Gonzalez MA, Pinder SE, Wencyk PM, et al. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol 1999; 187: 523-529.
24. Bukholm IK, Nesland JM, Karesen R, et al. E-cadherin and alpha-catenin, beta-catenin, and gamma-catenin protein expression in relation to metastasis in human breast-carcinoma. J Pathol 1998; 185: 262-266.
25. Candidus S, Bischoff P, Becker KF, et al. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res 1996; 56: 49-52.
26. Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 2002; 4: 5-8.